Evaxion A (EVAX) Return on Sales [ROS] (2023 - 2026)
Evaxion A (EVAX) reported Return on Sales [ROS] of -116.07% for Q2 2026, up 11613.66 percentage points from -11729.73% a year earlier and up 5.99 percentage points from the prior quarter.
Powered by 
Analysis
Evaxion A (EVAX) Return on Sales [ROS] (2023 - 2026) Analysis & Trends
For FY2025, Evaxion A posted Return on Sales [ROS] of -122.66%, up 317.89 percentage points from FY2024.
- By year, Return on Sales [ROS] came in at -440.55% in FY2024 (+29966.30 pp) and -30406.85% in FY2023.
- Five-year quarterly Return on Sales [ROS] spans a low of -11729.73% in Q2 2025 and a high of 40.34% in Q3 2025.
- Year over year, Return on Sales [ROS] has now increased in each of the last four quarters, with an average year-over-year change of +2438.25 percentage points over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at -122.06% (Q1 2026), -122.72% (Q4 2025) and 40.34% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 32.98% |
| 10 | Evaxion A | 17.56 Mn | -48.69 Mn | - | -116.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -116.07% |
| Mar 31, 2026 | -122.06% |
| Dec 31, 2025 | -122.72% |
| Sep 30, 2025 | 40.34% |
| Jun 30, 2025 | -11,729.73% |
| Mar 31, 2025 | -431.34% |
| Dec 31, 2024 | -3,298.36% |
| Sep 30, 2024 | -57.37% |
| Jun 30, 2024 | -2,974.68% |
| Mar 31, 2024 | -8,619.61% |
| Dec 31, 2023 | -588.93% |
API Access
Evaxion A Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "EVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();